Corticosteroids effect on caspase 3 expression in an in-vitro model of hypoxic brain cells

References

• Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515–25
   PubMed Web of Science ®Google Scholar
• Miller JS, Turan S, Baschat AA. Fetal growth restriction. Semin Perinatol 2008;32:274–80
   PubMed Web of Science ®Google Scholar
• Consensus Statement. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. J Am Med Assoc 1995;273:413–18
   Google Scholar
• Morrison JL. Sheep models of intrauterine growth restriction: fetal adaptations and consequences. Clin Exp Pharmacol Physiol 2008;35:730–43
   PubMed Web of Science ®Google Scholar
• Orgeig S, Crittenden TA, Marchant C, et al. Intrauterine growth restriction delays surfactant protein maturation in the sheep fetus. Am J Physiol Lung Cell Mol Physiol 2010;298:L575–83
   Web of Science ®Google Scholar
• Miller SL, Chai M, Loose J, et al. The effects of maternal betamethasone administration on the intrauterine growth-restricted fetus. Endocrinology 2007;148:1288–95
   PubMed Web of Science ®Google Scholar
• Vidaeff AC, Blackwell SC. Potential risks and benefits of antenatal corticosteroid therapy prior to preterm birth in pregnancies complicated by severe fetal growth restriction. Obstet Gynecol Clin North Am 2011;38:205–14, ix
   PubMed Web of Science ®Google Scholar
• Samuelsen GB, Pakkenberg B, Bogdanovic N, et al. Severe cell reduction in the future brain cortex in human growth-restricted fetuses and infants. Am J Obstet Gynecol 2007;197:56.e1–7
   PubMed Web of Science ®Google Scholar
• Spinillo A, Gardella B, Preti E, et al. Rates of neonatal death and cerebral palsy associated with fetal growth restriction among very low birthweight infants. A temporal analysis. BJOG, 2006;113:775–80
   PubMed Web of Science ®Google Scholar
• Yanney M, Marlow N. Paediatric consequences of fetal growth restriction. Semin Fetal Neonatal Med 2004;9:411–18
   PubMedGoogle Scholar
• Dammann O, Dammann CE, Allred EN, Veelken N. Fetal growth restriction is not associated with a reduced risk for bilateral spastic cerebral palsy in very-low-birthweight infants. Early Hum Dev 2001;64:79–89
   PubMed Web of Science ®Google Scholar
• Zhu C, Wang X, Qiu L, et al. Nitrosylation precedes caspase-3 activation and translocation of apoptosis-inducing factor in neonatal rat cerebral hypoxia-ischaemia. J Neurochem 2004;90:462–71
   PubMed Web of Science ®Google Scholar
• Zhu C, Wang X, Hagberg H, Blomgren K. Correlation between caspase-3 activation and three different markers of DNA damage in neonatal cerebral hypoxia-ischemia. J Neurochem 2000;75:819–29
   PubMed Web of Science ®Google Scholar
• Yang X, Yang S, Zhang J, et al. Role of Caspase 3 in neuronal apoptosis after acute brain injury. Chin J Traumatol 2002;5:250–3
   PubMedGoogle Scholar
• Yakovlev AG, Faden AI. Caspase-dependent apoptotic pathways in CNS injury. Mol Neurobiol 2001;24:131–44
   PubMed Web of Science ®Google Scholar
• Snigdha S, Smith ED, Prieto GA, Cotman CW. Caspase-3 activation as a bifurcation point between plasticity and cell death. Neurosci Bull 2012;28:14–24
   PubMed Web of Science ®Google Scholar
• Shen SH, Kwan AL, Chen YY, Wang ZX. Effect of silencing HIF-1alpha on proliferation, invasion and migration of glioblastoma U87 cells. Neurol Sci 2013;34:365--71
   PubMed Web of Science ®Google Scholar
• Kenig S, Frangez R, Pucer A, Lah T. Inhibition of cathepsin L lowers the apoptotic threshold of glioblastoma cells by up-regulating p53 and transcription of caspases 3 and 7. Apoptosis 2011;16:671–82
   PubMed Web of Science ®Google Scholar
• Dai S, Huang ML, Hsu CY, Chao KS. Inhibition of hypoxia inducible factor 1alpha causes oxygen-independent cytotoxicity and induces p53 independent apoptosis in glioblastoma cells. Int J Radiat Oncol Biol Phys 2003;55:1027–36
   PubMed Web of Science ®Google Scholar
• Ramin SM, Vidaeff AC, Gilstrap LC, et al. The effects of dexamethasone and betamethasone on surfactant protein-B messenger RNA expression in human type II pneumocytes and human lung adenocarcinoma cells. Am J Obstet Gynecol 2004;190:952–9
   PubMed Web of Science ®Google Scholar
• Almaas R, Saugstad OD, Pleasure D, et al. Effect of barbiturates on hydroxyl radicals, lipid peroxidation, and hypoxic cell death in human NT2-N neurons. Anesthesiology 2000;92:764–74
   PubMed Web of Science ®Google Scholar
• Moroz MA, Huang R, Kochetkov T, et al. Comparison of corticotropin-releasing factor, dexamethasone, and temozolomide: treatment efficacy and toxicity in U87 and C6 intracranial gliomas. Clin Cancer Res 2011;17:3282–92
   PubMed Web of Science ®Google Scholar
• Robe PA, Nguyen-Khac MT, Lambert F, et al. Dexamethasone inhibits the HSV-tk/ganciclovir bystander effect in malignant glioma cells. BMC Cancer 2005;5:32
   PubMed Web of Science ®Google Scholar
• Elimian A, Verma U, Canterino J, et al. Effectiveness of antenatal steroids in obstetric subgroups. Obstet Gynecol 1999;93:174–9
   PubMed Web of Science ®Google Scholar
• Bernstein IM, Horbar JD, Badger GJ, et al. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol 2000;182:198–206
   PubMed Web of Science ®Google Scholar
• Schaap AH, Wolf H, Bruinse HW, et al. Effects of antenatal corticosteroid administration on mortality and long-term morbidity in early preterm, growth-restricted infants. Obstet Gynecol 2001;97:954–60
   PubMed Web of Science ®Google Scholar
• Whitelaw A, Thoresen M. Antenatal steroids and the developing brain. Arch Dis Child Fetal Neonatal Ed 2000;83:F154–7
   PubMed Web of Science ®Google Scholar